Literature DB >> 14659792

Heat stress preconditioning and delayed myocardial protection: what is new?

Marie Joyeux-Faure1, Claire Arnaud, Diane Godin-Ribuot, Christophe Ribuot.   

Abstract

As other preconditioning phenomena, heat stress is able to induce a delayed myocardial protection against ischaemia-reperfusion injury by preserving ventricular function, preventing arrhythmia occurrence and reducing cellular necrosis. The development of heat stress response has been extensively studied in order to characterize the different steps of this form of preconditioning. It appears that chemical signals (such as nitric oxide, reactive oxygen species (ROS)) released by sublethal hyperthermic stress trigger a complex cascade of signalling events that include activation of protein kinase C (PKC) and mitogen-activated protein kinases (MAPK) and culminate in increased synthesis of inducible nitric oxide synthase, cyclooxygenase-2, antioxidant enzymes and protective proteins such as heat stress proteins (Hsps). A better understanding of this powerful protective adaptation of the cardiomyocyte is essential for the development of clinical applications and the design of cardioprotective pharmacological agents. The purpose of this letter is to review current information regarding the characteristics of heat stress preconditioning compared to other forms of late preconditioning.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14659792     DOI: 10.1016/j.cardiores.2003.08.012

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  10 in total

1.  Endogenous microRNAs induced by heat-shock reduce myocardial infarction following ischemia-reperfusion in mice.

Authors:  Chang Yin; Xiaoyin Wang; Rakesh C Kukreja
Journal:  FEBS Lett       Date:  2008-11-27       Impact factor: 4.124

2.  Effect of single and repeated heat stress on chemical signals of heat shock response cascade in the rat's heart.

Authors:  Gordana Ilievska; Suzana Dinevska-Kjovkarovska; Biljana Miova
Journal:  Cell Stress Chaperones       Date:  2017-11-24       Impact factor: 3.667

3.  Heat stress prevents lipopolysaccharide-induced apoptosis in pulmonary microvascular endothelial cells by blocking calpain/p38 MAPK signalling.

Authors:  Zhi-Feng Liu; Dong Zheng; Guo-Chang Fan; Tianqing Peng; Lei Su
Journal:  Apoptosis       Date:  2016-08       Impact factor: 4.677

4.  Heat shock proteins, end effectors of myocardium ischemic preconditioning?

Authors:  María Concepcion Guisasola; Maria del Mar Desco; Fernanda Silvana Gonzalez; Fernando Asensio; Elena Dulin; Antonio Suarez; Pedro Garcia Barreno
Journal:  Cell Stress Chaperones       Date:  2006       Impact factor: 3.667

5.  Sulindac confers high level ischemic protection to the heart through late preconditioning mechanisms.

Authors:  Ian Moench; Howard Prentice; Zach Rickaway; Herbert Weissbach
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-02       Impact factor: 11.205

6.  Heat stress in rat adriamycin cardiomyopathy: heat shock protein 25 and Myosin accumulation.

Authors:  Mirian Strauss; Alegna Rada; Félix Tejero; Tomás Hermoso
Journal:  J Toxicol Pathol       Date:  2010-12-16       Impact factor: 1.628

7.  The Effects of Prenatal Protein Restriction on β-Adrenergic Signalling of the Adult Rat Heart during Ischaemia Reperfusion.

Authors:  Kevin J P Ryan; Matthew J Elmes; Simon C Langley-Evans
Journal:  J Nutr Metab       Date:  2012-03-25

8.  Substantive hemodynamic and thermal strain upon completing lower-limb hot-water immersion; comparisons with treadmill running.

Authors:  Kate N Thomas; André M van Rij; Samuel J E Lucas; Andrew R Gray; James D Cotter
Journal:  Temperature (Austin)       Date:  2016-03-16

9.  Activation of kinase phosphorylation by heat-shift and mild heat-shock.

Authors:  Pamela Petrocchi; Stefania Quaresima; Maria Patrizia Mongiardi; Cinzia Severini; Roberta Possenti
Journal:  Cell Biol Int Rep (2010)       Date:  2010-08-03

Review 10.  Hypoxic Conditioning as a New Therapeutic Modality.

Authors:  Samuel Verges; Samarmar Chacaroun; Diane Godin-Ribuot; Sébastien Baillieul
Journal:  Front Pediatr       Date:  2015-06-22       Impact factor: 3.418

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.